The role of pharmacogenetics in the treatment of anxiety disorders and the future potential for targeted therapeutics

Volume: 17, Issue: 11, Pages: 1249 - 1260
Published: Oct 15, 2021
Abstract
Introduction Anxiety disorders (AD) are among the most common mental disorders worldwide. Pharmacotherapy, including benzodiazepines, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and tricyclic antidepressants is currently based on ‘trial-and-error,’ and is effective in a subset of patients or produces partial response only. Recent research proposes that treatment response and tolerability of the drugs...
Paper Details
Title
The role of pharmacogenetics in the treatment of anxiety disorders and the future potential for targeted therapeutics
Published Date
Oct 15, 2021
Volume
17
Issue
11
Pages
1249 - 1260
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.